Lorenz Räber: New Insights Into Silent Plaque Ruptures in AMI Patients
Lorenz Räber, Vice President of Swiss Society of Cardiology, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New publication European Heart Journal
In this study, we phenotyped lesions with silent plaque ruptures (PR) in non infarct related vessels of 336 AMI patients and found.
In larger plaque volume, positive remodeling, and thinner fibrous cap associated with rupture. Biomarkers (eg LDL-C, Lp(a), IFNy, interleukin-6; MMP-12; TNFa, hsCRP) were not correlated with multivessel plaque instability.
50% of plaques healed at 1 YR imaging with OCT.
All patients received high intensity statin therapy (at least), and the majority of healed plaques transformed into a fibrous morphology.
Although not powered for events, no excess in CV outcomes was noted in the PR group.
Great Editorial by Aloke Finn, Renu Virmani, CV Path Institute, Washington
Congratulations to the first author Ryota Kakizaki who spent a successful 3 YR fellowship at the Dep of Cardiology Insel Gruppe and we are proud on his persistence on this project published in the European Heart Journal this week.”
Title: Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study
Authors: Ryota Kakizaki, Flavio G Biccirè, Sylvain Losdat, Yasushi Ueki, Jonas D Häner, Hiroki Shibutani, Tatsuhiko Otsuka, Sarah Bär, Jacob Lønborg, Ernest Spitzer, George C M Siontis, Anna S Ondracek, Robert-Jan van Geuns, Yu-Jen Wang, Christian M Matter, Juan F Iglesias, David Spirk, Joost Daemen, Gregor Fahrni, Felix Mahfoud, Thomas Engstrøm, Irene M Lang, Konstantinos C Koskinas, Lorenz Räber
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management
-
Oct 30, 2026, 16:01Marilena Vrana: The Case for Retaining Immunoglobulins on the EU Critical Medicines List
-
Oct 30, 2026, 15:53Ilenia Calcaterra: Patient Blood Management Across Complex Hematological Conditions
-
Oct 30, 2026, 15:40Isabella Presch: The Practicalities of Gene Therapy Adoption in Hemophilia
-
Oct 30, 2026, 15:12Edward C.C. Wong: Navigating the Implications of the 2026 ASH Guidelines for Blood Donation
-
Oct 30, 2026, 14:53Pall T. Onundarson: Anticoagulation Guidelines Under the Influence of Pharmaceuticalisation
-
Oct 30, 2026, 14:27Isabella Presch: From Innovation to Accessibility in Cell and Gene Therapy
-
Oct 30, 2026, 14:00Abdul Mannan: A Negative PCR Does Not Exclude β-Thalassaemia
-
Oct 30, 2026, 13:53Matteo Foschi: Can Thrombolysis Safely Treat Stroke After Cardiac Procedures?